Published • loading... • Updated
Evonik Is Investing in Biotech Production Capacities for the Manufacture of Active Pharmaceutical Ingredients in Slovakia.
Summary by bionity.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Evonik is investing around €80 million in expanding its biotechnology production capacities at the Fermas site in Slovenská Ľupča, Slovakia. This investment will expand state-of-the-art downstream fermentation technology to support the contract manufacturing (CD) business...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
